Regulatory Roundup, Week of November 26, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Regulatory Roundup, Week of November 26, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

The European Medicines Agency (EMA) has announced a plan to address drug supply shortages following manufacturing problems. The plan was developed in collaboration with the European regulatory authorities in the EU member states.

The European Directorate for the Quality of Medicines and Healthcare (EDQM) has provided an update from the Pharmacopoeial Discussion Group (European Pharmacopoeia, Japanese Pharmacopoeia, and the US Pharmacopeia) meeting that took place on Nov. 6–7, 2012 in Rockville, Maryland. According to EDQM, 28 of the 35 General Chapters and 43 of the 62 excipient monographs have been harmonized.

The International Conference on Harmonization (ICH) has released an update from the Steering Committee and its Expert Working Groups meeting in San Diego, California, on Nov. 10–15, 2012. The meeting addressed reform to include the involvement of global regulators and reassure ICH’s commitment to harmonization.

FDA has released the following guidance documents and guidelines:

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here